Ventriculoperitoneal shunt infection in patients with hydrocephalus
PDF (Portuguese (Brazil))

Keywords

Hydrocephalus
Ventriculoperitoneal shunt
Risk factors

How to Cite

Ventriculoperitoneal shunt infection in patients with hydrocephalus. (2026). Revista Eletrônica Acervo Médico, 26, e25581. https://doi.org/10.25248/reamed.e25581.2026

Copyright © | All rights reserved.

The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.

Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.

Total reproduction
It is expressly prohibited and must be authorized by the journal.

Abstract

Objective: To synthesize the available evidence on the clinical and epidemiological profile of patients with hydrocephalus who develop ventriculoperitoneal shunt infection, analyzing the main factors associated with the occurrence of this complication and the strategies used for its prevention. Methods: This is an integrative literature review. The search was conducted in the PubMed and LILACS databases using descriptors related to ventriculoperitoneal shunting, infection, and risk factors. Clinical and observational studies published within the last 10 years were included, provided that they evaluated patients undergoing ventriculoperitoneal shunting and presented information on epidemiological profiles and factors associated with infection. Results: The studies demonstrated a higher occurrence of infection among younger patients, particularly in the pediatric population. Factors associated with infection included longer surgical time, revision surgeries, and emergency procedures. Preventive strategies included antibiotic prophylaxis, intraventricular antibiotics, reduction of surgical time, and control of the operating environment. Conclusion: Ventriculoperitoneal shunt infection is an important complication of hydrocephalus treatment, and the recognition of risk factors and adoption of preventive measures are essential to reduce its occurrence.

PDF (Portuguese (Brazil))

References

1. ABUHADI M, et al. Predictors and outcome of ventriculoperitoneal shunt infection: A retrospective single-center study. Cureus, 2022; 14(7): e27494.

2. AL RIFAI M, et al. Machine learning-based assessment of seizure risk predictors in myelomeningocele patients: a single-center retrospective cohort study. Qatar Medical Journal, 2025; 2025: 15.

3. ATES N, et al. Usage of a bundle application process in decreasing ventriculoperitoneal shunt infections. Turkish Neurosurgery, 2020; 30(4): 550-556.

4. AYOGU OM, et al. Ventriculoperitoneal shunt infection rate and other associated complications of VP shunt insertion in Abuja, Nigeria. World Neurosurgery X, 2024; 23: 100332.

5. BACKLUND A, et al. Impact of surgical timing on ventriculoperitoneal shunt failure rates: A population-based cohort study. World Neurosurgery, 2025.

6. BOBAN M, et al. Ventriculoperitoneal shunt surgery in Brunei Darussalam: a population-based perspective. Asian Journal of Neurosurgery, 2023; 18(3): 597-601.

7. CHAN V, et al. Risk factors for 30-day postoperative infection in pediatric ventricular shunts for hydrocephalus. World Neurosurgery, 2025; 195: 123676.

8. CHEN FM, et al. Efficacy of ventriculoperitoneal shunt for postoperative central nervous system infection complicated with hydrocephalus. Asian Journal of Neurosurgery, 2024.

9. CHRISTIAN EA, et al. Surgical management of hydrocephalus secondary to intraventricular hemorrhage in the preterm infant. Journal of Neurosurgery: Pediatrics, 2016.

10. DAOUD S, et al. Investigating the types of microorganisms causing cerebrospinal fluid shunt infection in King Abdullah University Hospital in Jordan. Qatar Medical Journal, 2025; 2025: 11.

11. DAVIS SE, et al. Does age or other factors influence the incidence of ventriculoperitoneal shunt infections? Pediatric Neurosurgery, 1999; 30(5): 253-257.

12. DEMIR OO, et al. Challenges in the management of multidrug-resistant Gram-negative bacterial meningitis in children: a decade of clinical insights. BMC Pediatrics, 2025.

13. DE SOUZA DN, et al. Factors affecting infection risk and revision rates in shunted pediatric hydrocephalus: 10 years of data from a single academic center. Child's Nervous System, 2025; 41(1): 320.

14. ELGORMUS N, et al. Management of recurrent ventriculoperitoneal shunt infections in adult patients. Antibiotics, 2025; 14(1): 77.

15. ERPS A, et al. Risk factors and epidemiology of pediatric ventriculoperitoneal shunt infection. Pediatric International, 2018; 60(12): 1056-1061.

16. ESTEBAN ESTALLO L, et al. Risk factors for shunt-dependent hydrocephalus after spontaneous subarachnoid hemorrhage. Neurocirugía, 2024; 35(4): 196-204.

17. FERNÁNDEZ V JP, et al. Central nervous system infections associated with CSF shunt devices in children, at a national reference hospital. Revista Chilena de Infectología, 2021.

18. HAUPTMAN JS, et al. Predictors of fast and ultrafast shunt failure in pediatric hydrocephalus: a Hydrocephalus Clinical Research Network study. Journal of Neurosurgery: Pediatrics, 2021; 27(3): 277-286.

19. KESTLE JRW, et al. A standardized protocol to reduce cerebrospinal fluid shunt infection: the Hydrocephalus Clinical Research Network Quality Improvement Initiative. Journal of Neurosurgery: Pediatrics, 2011; 8(1): 22-29.

20. KHALIL F, et al. Revision and infection rate in 728 shunt-treated adult hydrocephalus patients: a single-center retrospective study. World Neurosurgery, 2024; 192: e402-e409.

21. KHUNCHAMNAN S, et al. An antibiotic prophylaxis for prevention of ventriculoperitoneal shunt infection using intraventricular injection and shunt soaking with vancomycin and gentamicin. Antibiotics, 2026; 15(1): 60.

22. KOMIOTIS C, et al. Etiology and risk factors for shunt revision in adult hydrocephalus: a single-center retrospective cohort study. Brain Sciences, 2026; 16(3): 318.

23. LEE JK, et al. Incidence and risk factors of ventriculoperitoneal shunt infections in children: a study of 333 consecutive shunts in 6 years. Journal of Korean Medical Science, 2012; 27(12): 1563-1568.

24. MCGIRT MJ, et al. Risk factors for pediatric ventriculoperitoneal shunt infection and predictors of infectious pathogens. Clinical Infectious Diseases, 2003; 36(7): 858-862.

25. NAZWAR TA, et al. Complications of ventriculoperitoneal shunts: Infection and exposure in hydrocephalus patients: A case series. Surgical Neurology International, 2024; 15: 313.

26. OLIVEIRA ICT, et al. Risk factors for malfunction of ventriculoperitoneal shunts performed by medical residents in children: an exploratory study. Arquivos Brasileiros de Neurocirurgia, 2022; 41(3): 239-244.

27. ÖNAL P, et al. Pediatric ventriculoperitoneal shunt infections and the risk of multiloculated hydrocephalus. Turkish Archives of Pediatrics, 2025.

28. OKAMURA Y, et al. Detailed standardized protocol to prevent cerebrospinal fluid shunt infection. Journal of Neurosurgery, 2019; 132(3): 755-759.

29. PAN P. Outcome analysis of ventriculoperitoneal shunt surgery in pediatric hydrocephalus. Journal of Pediatric Neurosciences, 2018.

30. PAUDEL P, et al. Ventriculoperitoneal shunt complication in pediatric hydrocephalus: risk factor analysis from a single institution in Nepal. Asian Journal of Neurosurgery, 2020.

31. PELEGRÍN I, et al. Management of ventriculoperitoneal shunt infections in adults: analysis of risk factors associated with treatment failure. Clinical Infectious Diseases, 2017; 64(8): 989-997.

32. RAVINDRA VM, et al. Comparison of outcomes in the management of abdominal pseudocyst in children with shunted hydrocephalus: a Hydrocephalus Clinical Research Network study. Journal of Neurosurgery: Pediatrics, 2023.

33. SANCHEZ DJ, et al. Implementation of a shunt insertion protocol and its effect on institutional shunt infection rates. Cureus, 2025.

34. SIGNORELLI F, et al. Risk factors for ventriculoperitoneal shunt infection: a systematic review and meta-analysis. Brain Sciences, 2025; 15(10): 1055.

35. STEVENS NT, et al. Ventriculoperitoneal shunt-related infections caused by Staphylococcus epidermidis: pathogenesis and implications for treatment. British Journal of Neurosurgery, 2012; 26(6): 792-797.

36. SUN Z, et al. Factors affecting development of infection after implantation of ventriculoperitoneal shunts in patients with posttraumatic hydrocephalus. World Neurosurgery, 2022; 166: e647-e653.

37. TYLER K, et al. Risk of ventriculoperitoneal shunt infection with coexisting percutaneous endoscopic gastrostomy tube and associated factors. Heliyon, 2020; 6(3): e03523.

38. WORKING GROUP ON NEUROSURGICAL OUTCOMES MONITORING, et al. Primary ventriculoperitoneal shunting outcomes: a multicentre clinical audit for shunt infection and its risk factors. Hong Kong Medical Journal, 2016; 22(5): 410-419.

39. YAKUT N, et al. Ventriculoperitoneal shunt infections and re-infections in children: a multicentre retrospective study. British Journal of Neurosurgery, 2018; 32(2): 196-200.

40. ZHANG H, et al. Correlation between cerebrospinal fluid abnormalities before ventriculoperitoneal shunt and postoperative intracranial infection in adult patients with hydrocephalus: a clinical study. Frontiers in Neurology, 2022; 13: 1023761.